Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 1
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
1| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8722065 | BONDLIDOlidocaine | product | Nov 2028 |
| Product | Exclusivity | Until |
|---|---|---|
| BONDLIDOLIDOCAINE | NP New product | Sept 2028 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| BONDLIDO | lidocaine | system, topical | 83708-111NDA |
Compare
Other companies listing lidocaine
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- Strides Pharma Science Limited5 sites · 230 NDC
- Par Health USA, LLC5 sites · 211 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- PureTek Corporation2 sites · 178 NDC
- Nivagen Pharmaceuticals LLC2 sites · 106 NDC
- ASO Pharmaceutical Co. Ltd.2 sites · 10 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Proficient Rx LP1 site · 1,729 NDC
Enquiry
Common questions
- Is MEDRx USA, Inc. FDA approved?
- MEDRx USA, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does MEDRx USA, Inc. make?
- 1 product is listed under MEDRx USA, Inc. in the openFDA NDC Directory, most often as system. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.